Bank of America
IMMX icon

Bank of America’s Immix Biopharma IMMX Stock Holding History

Bank of America’s Portfolio IMMX Stock Details IMMX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$375K Buy
41,131
+41,115
+256,969% +$302K ﹤0.01% 5047
2025
Q4 		$84 Buy
16
+4
+33% +$16 ﹤0.01% 6851
2025
Q3 		$25 Sell
12
-127
-91% -$305 ﹤0.01% 8138
2025
Q2 		$288 Buy
139
+19
+16% +$38 ﹤0.01% 7778
2025
Q1 		$202 Buy
120
+6
+5% +$11 ﹤0.01% 7689
2024
Q4 		$251 Sell
114
-1
-0.9% -$2 ﹤0.01% 7543
2024
Q3 		$171 Hold
115
– – ﹤0.01% 7605
2024
Q2 		$228 Buy
+115
New +$264 ﹤0.01% 7532
2024
Q1 		– Sell
-1,594
Closed -$11K – 7943
2023
Q4 		$11K Buy
+1,594
New +$7.22K ﹤0.01% 6897
2023
Q1 		– Sell
-10
Closed -$22 – 8019
2022
Q4 		$22 Buy
+10
New +$13 ﹤0.01% 7968

Other funds holding IMMX

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SVCM
Saturn V Capital Management Austin, Texas $552M AUM 551.78% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return

Bank of America's IMMX Position: Q1 2026 in Review

Bank of America increased its Immix Biopharma (IMMX) stake by 256,969% in Q1 2026, buying an estimated $302K and bringing the position to 41,131 shares worth $375K. The position accounts for ﹤0.01% of the portfolio, ranked #5047.

Bank of America first reported a position in IMMX in Q4 2022 and has held it in 10 quarters since. 77 funds tracked by Wall St. Rank hold IMMX as of Q1 2026.

  • Bank of America held 41,131 shares of Immix Biopharma worth $375K as of Q1 2026.
  • Bank of America bought 41,115 Immix Biopharma shares in Q1 2026, an estimated $302K.
  • Immix Biopharma made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5047 holding.
  • Bank of America first reported a position in Immix Biopharma in Q4 2022 and has held it in 10 quarters since.
  • 77 funds tracked by Wall St. Rank held Immix Biopharma as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.